Duopharma Biotech (7148.KU) - Malaysia
(2nd) quarter ended Jun 30:
Figures Are In Ringgit (MYR).
2026 2025
Revenue 234,356,000 221,782,000
PreTax Profit 39,300,000 26,584,000
Net Profit 29,869,000 20,204,000
Earnings Per Share 3.11 Sen 2.10 Sen
Dividend 1.50 Sen 1.50 Sen
6 months ended Jun 30:
Revenue 482,236,000 484,520,000
PreTax Profit 79,708,000 60,321,000
Net Profit 60,586,000 45,844,000
Earnings Per Share 6.30 Sen 4.77 Sen
Dividend 1.50 Sen 1.50 Sen
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.